Effects of Dry Needling and Strain Counter Strain Technique in Myofascial Trigger Points of Upper Trapezius

September 18, 2020 updated by: Riphah International University

Combined Effects of Dry Needling and Strain Counter Strain Technique in Myofascial Trigger Points of Upper Trapezius

To determine the effects of Dry Needling and Strain Counter Strain Technique in Myofascial Trigger Points of Upper Trapezius

Study Overview

Detailed Description

It is Randomized Controlled trail will be conduct in Mayo Hospital Lahore and Alnoor Hospital Awan town Lahore. Non probability consecutive sampling technique will be used to collect the data. Each group contain the 14 patients, Patient will be divided into two groups. Group A will be experimental group treated by Dry needling and strain counter strain with baseline treatment and Group B will be control group treated by Strain counter strain with baseline treatment(Hot pack 10 mints,stretching,Neck isometrics). Neck Disability index (NDI) ,visual analogue scale(VAS) and goniometer will be used as data collecting tools.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lahore, Pakistan, 54000
        • Mayo Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with non-specific neck pain, having active myofascial trigger points in upper trapezius muscle.
  • Patient of both gender under the age of 20-40 year
  • bilateral pain involving the upper trapezius
  • a duration of pain of at least 3 months
  • pain localized in the cervical and occipital regions but not in the orofacial region.
  • restricted cervical range of motion(side flexion)

Exclusion Criteria:

  • history of traumatic injuries (e.g., contusion, fracture, and whiplash injury)
  • needle phobia patients.
  • systemic diseases such as blood coagula tion disorders, chronic pain syndrome, cancer,allergies fibromyalgia, systemic lupus erythematous, and psoriatic arthritis.
  • cervical spine surgery patients.
  • orofacial pain and temporomandibular disorders
  • neurologic disorders (e.g., trigeminal neuralgia or occipital neuralgia)
  • medical diagnosis of any primary headache (tension type or migraine) clinical diagnosis of cervical radiculopathy or myelopathy
  • history of previous physical therapy intervention for the cervical region in last 6 month
  • use of anticoagulants, opioids or antiepileptic medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dry needling
Hot pack 10 mints,stretching,Neck isometrics, dry needling(DN) and Strain counterstrain(SCS)
Hot pack 10 mints,stretching,Neck isometrics, dry needling(DN) and Strain counterstrain(SCS)
Active Comparator: Strain counter strain
Hot pack 10 minutes, stretching,Neck isometrics, Strain counter strain (S C S)
Hot pack 10 mints, stretchings,Neck isometrics, Strain counterstrain(SCS)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: 4 months
The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain on an eleven-point numerical scale. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).
4 months
Range of Motion
Time Frame: 4 months
Standard Goniometer will be used.Higher score shows improvement.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability
Time Frame: 4 months
Scoring: For each section the total possible score is 5: if the first statement is marked the section score = 0, if the last statement is marked it = 5. If all ten sections are completed the score is calculated as follows: Example:16 (total scored) 50 (total possible score) x 100 = 32% If one section is missed or not applicable the score is calculated: 16 (total scored) 45 (total possible score) x 100 = 35.5% Minimum Detectable Change (90% confidence): 5 points or 10 %points
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2019

Primary Completion (Actual)

June 20, 2020

Study Completion (Actual)

August 28, 2020

Study Registration Dates

First Submitted

February 11, 2020

First Submitted That Met QC Criteria

February 25, 2020

First Posted (Actual)

February 26, 2020

Study Record Updates

Last Update Posted (Actual)

September 22, 2020

Last Update Submitted That Met QC Criteria

September 18, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Point Pain, Myofascial

Clinical Trials on Dry Needling

3
Subscribe